A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation.
Meiser
B M
BM
Department of Cardiac Surgery, Ludwig-Maximilians University of Munich, Germany.
Reiter
C
C
Ebel
M
M
Uberfuhr
P
P
Wenke
K
K
Reichenspurner
H
H
Rieber
E
E
Riethmüller
G
G
Reichart
B
B
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D015704:CD4 Antigens / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D001379:Azathioprine